Biotech industry veteran to lead Tagworks as the company prepares to bring its novel platform and lead antibody-drug conjugate (ADC) program for solid tumors into the clinic in 2025 Founding CEO Marc Robillard, Ph.D., will continue in role of Chief Scientific Officer and as a member of the Board Nijmegen, Netherlands and BOSTON—(Newswire)—Tagworks Pharmaceuticals BV (“Tagworks”), … Continue reading Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer